Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells

H. Kirschke, R. Eerola, V. K. Hopsu-Havu, D. Brömme, E. Vuorio

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Abstract

Several tumour-forming cell lines are known to overproduce the lysosomal cysteine peptidase cathepsin L. We have used an antisense approach to investigate whether inhibition of cathepsin L overexpression in two malignant cell lines (myeloma SP cells and L cells) reduces their tumorigenic potential. Two different cDNA fragments of murine cathepsin L were inserted in the antisense direction into the pcDNA3 vector, and SP and L cells were stably transfected with these plasmid constructs. Several of the selected clones expressing the antisense transcript showed specific reduction of the mRNA level and the intracellular activity of cathepsin L, and a greatly diminished amount of secreted procathepsin L. When tested in Balb/c nu/nu mice, the cell lines with low cathepsin L activity exhibited a significantly decreased potential for tumour growth when compared with control cells expressing wild-type levels of cathepsin L activity. This observation suggests that cathepsin L is a critical factor in tumour growth. Copyright (C) 2000.

Original languageEnglish
Pages (from-to)787-795
Number of pages9
JournalEuropean Journal of Cancer
Volume36
Issue number6
DOIs
StatePublished - Apr 2000

Keywords

  • Antisense RNA
  • Cathepsin B
  • Cathepsin L
  • L cells
  • Myeloma SP cells
  • Procathepsin L
  • Tumour growth

Fingerprint

Dive into the research topics of 'Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells'. Together they form a unique fingerprint.

Cite this